viral vector-based cancer vaccine VAC85135
Term · Oncology and biomedicine · MLC-T-ONC-017512
An off-the-shelf (OTS) cancer vaccine consisting of a viral vector encoding certain neoantigens, with potential immunomodulating and antineoplastic activities. Upon administration of the viral vector-based cancer vaccine VAC85135, the expressed neoantigens elicit a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing these neoantigens.
| Identifier | MLC-T-ONC-017512 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017512",
"term": "viral vector-based cancer vaccine VAC85135",
"field": "Oncology and biomedicine",
"definition": "An off-the-shelf (OTS) cancer vaccine consisting of a viral vector encoding certain neoantigens, with potential immunomodulating and antineoplastic activities. Upon administration of the viral vector-based cancer vaccine VAC85135, the expressed neoantigens elicit a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing these neoantigens.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/viral-vector-based-cancer-vaccine-vac85135/"
}
Record 17,259 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.